Domingo Palacios-Ceña1, Lidiane Lima Florencio1, Valentín Hernández-Barrera2, Cesar Fernandez-de-Las-Peñas1, Javier de Miguel-Diez3, David Martínez-Hernández4, David Carabantes-Alarcón4, Rodrigo Jimenez-García4, Ana Lopez-de-Andres4, Marta Lopez-Herranz5. 1. Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, Alcorcón, 28922 Madrid, Spain. 2. Preventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Universidad Rey Juan Carlos, Alcorcón, 28922 Madrid, Spain. 3. Respiratory Care Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense de Madrid, 28040 Madrid, Spain. 4. Department of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain. 5. Faculty of Nursing, Physiotherapy and Podology, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Abstract
(1) Background: To assess time trends in the incidence and in-hospital outcomes of urinary tract infection (UTI) in older people (≥65 years) in Spain (2001-2018) according to sex and to identify the factors independently associated with in-hospital mortality (IHM). (2) Methods: Using the Spanish National Hospital Database, we analyzed comorbidity, procedures, diagnosis, isolated microorganisms, and outcomes. (3) Results: We included 583,693 admissions (56.76% women). In both sexes, the incidence increased with age over time (p < 0.001). In men and women, the highest IHM was found among the oldest patients (>84 years) with values of 9.16% and 8.6%, respectively. The prevalence of bacteremia increased from 4.61% to 4.98% from 2001 to 2018 (p < 0.001) and sepsis decreased from 3.16% to 1.69% (p < 0.001). The risk of dying increased with age (>84 years) (OR 3.63; 95% CI 3.5-3.78) and with almost all comorbidities. Urinary catheter was a risk factor for women (OR 1.1; 95% CI 1.02-1.18) and protective for men (OR 0.71; 95% CI 0.66-0.76). Isolation of Staphylococcus aureus increased the risk of IHM by 40% among men (OR 1.4; 95% CI 1.28-1.53). After adjusting for confounders, IHM decreased over time. (4) Conclusions: The incidence of UTIs was higher in older patients and increased over time; however, IHM decreased during the same period. Female sex, age, comorbidities, sepsis, and a Staphylococcus aureus isolation increased risk of IHM.
(1) Background: To assess time trends in the incidence and in-hospital outcomes of urinary tract infection (UTI) in older people (≥65 years) in Spain (2001-2018) according to sex and to identify the factors independently associated with in-hospital mortality (IHM). (2) Methods: Using the Spanish National Hospital Database, we analyzed comorbidity, procedures, diagnosis, isolated microorganisms, and outcomes. (3) Results: We included 583,693 admissions (56.76% women). In both sexes, the incidence increased with age over time (p < 0.001). In men and women, the highest IHM was found among the oldest patients (>84 years) with values of 9.16% and 8.6%, respectively. The prevalence of bacteremia increased from 4.61% to 4.98% from 2001 to 2018 (p < 0.001) and sepsis decreased from 3.16% to 1.69% (p < 0.001). The risk of dying increased with age (>84 years) (OR 3.63; 95% CI 3.5-3.78) and with almost all comorbidities. Urinary catheter was a risk factor for women (OR 1.1; 95% CI 1.02-1.18) and protective for men (OR 0.71; 95% CI 0.66-0.76). Isolation of Staphylococcus aureus increased the risk of IHM by 40% among men (OR 1.4; 95% CI 1.28-1.53). After adjusting for confounders, IHM decreased over time. (4) Conclusions: The incidence of UTIs was higher in older patients and increased over time; however, IHM decreased during the same period. Female sex, age, comorbidities, sepsis, and a Staphylococcus aureus isolation increased risk of IHM.
Authors: Kalin M Clifford; Eliza A Dy-Boarman; Krystal K Haase; Kristen Maxvill; Steven E Pass; Carlos A Alvarez Journal: Expert Rev Anti Infect Ther Date: 2016-01-14 Impact factor: 5.091
Authors: Florian Wagenlehner; Björn Wullt; Stefania Ballarini; Daniel Zingg; Kurt G Naber Journal: Expert Rev Pharmacoecon Outcomes Res Date: 2017-07-31 Impact factor: 2.217
Authors: E Álvarez Artero; A Campo Nuñez; M Garcia Bravo; O Cores Calvo; M Belhassen Garcia; J Pardo Lledias Journal: Rev Clin Esp (Barc) Date: 2019-02-14
Authors: A Aguinaga; A Gil-Setas; A Mazón Ramos; A Alvaro; J J García-Irure; A Navascués; C Ezpeleta Baquedano Journal: An Sist Sanit Navar Date: 2018-04-30 Impact factor: 0.829
Authors: Kyle R Jackson; Jennifer D Motter; Sunjae Bae; Amber Kernodle; Jane J Long; William Werbel; Robin Avery; Christine Durand; Allan B Massie; Niraj Desai; Jacqueline Garonzik-Wang; Dorry L Segev Journal: Am J Transplant Date: 2020-06-28 Impact factor: 9.369
Authors: Myriam Gharbi; Joseph H Drysdale; Hannah Lishman; Rosalind Goudie; Mariam Molokhia; Alan P Johnson; Alison H Holmes; Paul Aylin Journal: BMJ Date: 2019-02-27
Authors: M M Rodríguez Del Águila; A Sorlózano-Puerto; M A Fernández-Sierra; J M Navarro Marí; J Gutiérrez Fernández Journal: Rev Esp Quimioter Date: 2022-06-06 Impact factor: 2.515